Emyria LtdASX: EMD

Emyria receives $1,162,000 R&D Tax Incentive Refund

· Issued by Emyria Ltd

Filed with ASX · · 2 pages · English

Emyria Limited (ASX: EMD) (Emyria or the Company), a data-backed drug development and care delivery company, is pleased to announce that it has received a Research and Development (R&D) Tax Incentive refund of $1,162,134 for the financial year 2020/2021. Emyria Managing Director Dr Michael Winlosaid: “Combined with the recent strategic investment from Tattarang, this R&D tax incentive refund streng

Emyria Ltd on 6ix

Earlier from Emyria

Later from Emyria

All Emyria news releases